Skip to content
Home/Companies/Biotech/Cytos Biotechnology AG

Cytos Biotechnology AG

Biotech·Switzerland·Exited 2002·Held 3yr
Entry
1999
Hold
3yr
Exit
2002

Who owns Cytos Biotechnology AG?

Cytos Biotechnology AG is a Swiss Biotech company, formerly owned by HealthCap, exited in 2002 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap (early funds) · 1996 · VC

Key facts

HQSwitzerland
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2002

More from HealthCap (early funds)

Other portfolio companies in the same fund.

Affibody AB
Active
BiotechSweden· 2001
Pharmion Corp.
Exited 2003
PharmaUS· 2001
Gyros AB
Exited 2016
MedTechSweden· 2000
to Mesa Laboratories
Actelion Holding Ltd
Exited 2017
PharmaSwitzerland· 1997
to Johnson & Johnson
Biotage AB (Pyrosequencing AB)
Exited 2000
BiotechSweden· 1997
Carmeda AB
Exited 2005
MedTechSweden· 1996
to W.L. Gore & Associates

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Cytos Biotechnology AG?

Cytos Biotechnology AG was formerly owned by HealthCap, exited in 2002. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue